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Processing of dengue virus type 2 polyprotein precursor NS3-NS4A-NS4B-NS5 could be mediated by the

catalytically active NS3 protease domain and NS2B in trans at the dibasic sites NS3-NS4A and NS4B-NS5.

Subcellular localization of the unprocessed precursor NS3-NS4A-NS4B-NS5 showed that it was confined to a
distinct subcellular organelle in the cytoplasm, which was distinct from the distribution of the mature NS5.

Dengue virus type 2 (DEN-2), a member of the family
Flaviviridae, contains a single-stranded RNA genome of
10,723 nucleotides (New Guinea C strain), having a type 1
cap at the 5' end, but lacking a poly(A) tract at the 3' end (for
reviews, see references 1, 4, 23, 27, and 28). The genomic
RNA is of positive-strand polarity, having a single open
reading frame that encodes a polyprotein of 3,391 amino
acids, which is processed into three structural and at least
seven nonstructural proteins so far identified. The gene
order is 5'-C-prM-E-NS1-NS2A-NS2B-NS3-NS4A-NS4BNS5-3', where C, prM, and E are the structural proteins and
NS1 through NS5 represent the nonstructural proteins. The
processing of the polyprotein precursor occurs cotranslationally as well as posttranslationally and is performed by
either the host signalase in association with the membranes
of the endoplasmic reticulum or the viral protease(s) (reviewed in reference 4). For the construction of expression
plasmids to study the processing of the DEN-2 polyprotein
precursors, a recombinant vaccinia virus expression vector
(pTM1) was used (18). This vector contains a T7 promoter
(PT7) and an encephalomyocarditis virus (EMCV) 5'-untranslated region upstream of the target gene, which allows
cap-independent translation of the transcripts; with this
system, the target gene has been reported to be expressed at
high levels of RNA as well as protein because of more
efficient utilization of the transcripts by cap-independent
translation (7, 19). Figure 1 shows the polyprotein precursor
of DEN-2 and the location of the coding sequences of the
nonstructural proteins used in this study. These expression
plasmids were constructed by standard recombinant DNA
techniques (17) as follows. The details of the construction of
the intermediate plasmids pLZ-3PCR, pLZ-3, pLZ-5, pLZ123, and pLZ-2B-3-4A-4B-5 and the plasmid pLZ-12345
encoding all the nonstructural proteins of DEN-2 will be
described elsewhere (unpublished data).
pLZ-345. The pLZ-3PCR plasmid was digested with NsiI
(nucleotide 4696) and EcoRI in the pTM1 vector and then
ligated with two other DNA fragments; one of these was
obtained from the plasmid pLZ-3 by digesting with NsiI and
PvuII (nucleotides 4696 to 5447), and the other was from the
cDNA clone pPM-A1O (14) by digesting with PvuII and
EcoRI (nucleotides 5447 to 8761). This cloning procedure

resulted in the plasmid pLZ-310 containing the coding sequence NS3-NS4A-NS4B-truncated NS5. pLZ-310 was then
digested with StuI to release a 900-bp fragment between
nucleotide 7872 and a site in the vector. This fragment was
replaced by the StuI fragment (2.7 kb) from pLZ-5, and the
plasmid pLZ-345 was obtained containing the region from
NS3 to NS5 (nucleotides 4522 to 10543).
pLZ-2B. A polymerase chain reaction (PCR) was performed with two oligonucleotides, 5'-AGCTGGCCACTAA
ATGAGGCT-3' (nucleotides 4132 to 4152) and 5'-ttaCCGTT
GTlClTCTCACTTCCCACAG-3' (complementary to nucleotides 4498 to 4521), on the pLZ-123 template, and the PCR
fragment was cloned into the pTM1 vector at the NcoI site to
obtain the pLZ-2B plasmid containing the complete NS2B
coding sequence and ending with the termination codon
TAA (tta in the oligonucleotide).
pLZ-2B3(pro) and pLZ-3(pro). The plasmid pLZ-2B345
was digested with XhoI (nucleotide 5426) and XbaI (in the
pTMl vector) and cloned into the pTMl vector digested with
XbaI and XhoI to obtain the plasmid pLZ-2B3(pro) encoding
the complete NS2B and the N-terminal region of NS3
(-50%). pLZ-3(pro) was constructed by a procedure similar
to the procedure followed for pLZ-2B3(pro), but using
pLZ-3 instead of the pLZ-2B345 plasmid.
pLZ-3(50%oC)45. pLZ-345 was digested with XhoI (nucleotide 5426) and XbaI (in the pTM1 vector), and the large
fragment containing the C-terminal NS3(50%)45 sequences
was ligated with the small XbaI-XhoI fragment obtained
from the pTM1 vector; this step gave rise to the plasmid
pLZ-3(50%C)45. The N terminus of the clone contained 13
amino acid residues from the multiple cloning sites of the
pTM-1 vector.
pLZ-3*45. Two oligonucleotides, 5'-GCTGGAGTATTGT
GGGAT-3' (nucleotides 4522 to 4539) and 5'-TTATGCAT

TAGAACAGCGCCGCGTGTGACAGCCCACATTGTATT3' (complementary to nucleotides 4660 to 4703), were used

for PCR; the longer one contained the desired mutation
converting histidine into alanine in the active-site catalytic
triad (as shown by an underline); an additional mutation (as
shown by an overline) was found to be present in three
independent clones, which resulted in the His--Asn change;
this mutation may have resulted from the G- T change at the
3'-terminal nucleotide of the oligonucleotide primer used for
PCR. The resulting mutant PCR fragment (nucleotides 4522
to 4703) was cloned into the pTM1 vector at the NcoI site.
The resulting plasmid, pLZ-3*PCR, was digested with NsiI
(nucleotide 4696) and XbaI and ligated with the NsiI-XbaI
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FIG. 1. Plasmids encoding DEN-2 nonstructural proteins and
their precursors used for the infection-transfection protocol. In the
top of the figure, a long horizontal bar indicates the open reading
frame encoding the DEN-2 precursor polyprotein, and the vertical
lines within the bar denote the boundaries of individual mature
proteins which result from the processing of the precursor protein.
The gene order of the precursor protein consists of the structural
region encoding the C, prM, and E proteins and the nonstructural
region which encodes NS1, NS2A, NS2B, NS3, NS4A, NS4B, and
NS5 proteins (see reference 4 for a review). Single lines extending
from the bar toward the 5' and 3' ends denote the untranslated
region (UTR) of the DEN-2 RNA. The sizes are not drawn to scale.
The pLZ series of plasmids indicate the locations of the coding
sequences of the various nonstructural proteins and their precursors
used in this study. The experimental details of the plasmid constructs are given in the text. *, mutation of His--Ala in the active
site of the protease domain of the NS3 protein, which is indicated by
a black box.

fragment from pLZ-345. The resulting plasmid, pLZ-3*45,
contained the complete NS3 to NS5 coding sequence with a
mutation which changed histidine into alanine at the conserved active site catalytic triad of the NS3 protease domain.
All PCR-derived clones were verified by sequence analysis.
To examine the processing, we first infected monkey
kidney (CV-1) cells with the recombinant vaccinia virus
vTF7-3 to provide T7 RNA polymerase (9, 18); this was
followed by transfection of an expression plasmid by a
protocol based on liposome-mediated DNA uptake. This
transient expression system is referred to as an infectiontransfection protocol (18). The expression plasmid pLZ-345
gave rise to a 180-kDa protein in the transfected CV-1 cells
which could react with either the anti-NS3 or anti-NS5
antibodies, whereas no cleavage of the precursor NS3NS4A-NS4B-NS5 (hereafter referred to as NS345) was
observed (data not shown), although the N-terminal region
of NS3 contains a protease domain (10). Yellow fever virus
(YF) precursor NS345356 containing one-third of the NS5
protein (3) and the dengue virus type 4 (DEN-4) precursor
NS345 (2) also did not undergo processing when expressed
alone. The failure of the polyprotein precursor NS345 to
undergo processing suggested that the catalytically active
NS3 alone was not sufficient for cleavages at the NS3-NS4A
and NS4B-NS5 sites and that one or more nonstructural
proteins were also required. NS2B was a good candidate for
that role because of the recent reports that NS2B is required
for NS3 protease activity (2, 3, 6, 8, 22). To test whether
NS2B could mediate processing of NS345 in trans, we
cotransfected an expression clone encoding NS2B with the
plasmid encoding NS345. When the labeled cell lysates from
the transfected cells were analyzed by immunoprecipitation,
it was found that the NS345 polyprotein precursor underwent processing as indicated by the release of NS3 and NS5
(Fig. 2A and B, lanes 2), which would require cleavages at

both the NS3-NS4A and NS4B-NS5 sites. These data indicate that NS2B plays an important role in the processing of
NS345 at both the NS3-NS4A and NS4B-NS5 sites. However, the YF polyprotein substrate NS345356 containing
one-third of the NS5 protein was processed by NS2B supplied in trans only at the NS4B-NS5 site, and no detectable
cleavage of the NS3-NS4A site was observed (3). In contrast, the DEN-2 NS345 substrate used in our study contains
the entire NS5 sequence and could undergo cleavages at
both the NS3-NS4A and NS4B-NS5 sites (Fig. 2A and B).
From these results, an intact NS5 sequence seems to be
important for cleavage at the NS3-NS4A site by NS2B. We
found that the cleavage at the NS3-NS4A site is exquisitely
sensitive to conformation of the polyprotein precursor; the
most efficient cleavage, similar to the pattern in DEN-2infected cells, was observed when the precursor NS12345
containing the entire nonstructural region was used as the
substrate (29). Thus, it appears that conformation of a
precursor protein may play an important role in the processing events mediated by a viral protease. To investigate
whether the NS3 protease domain was important for the
processing of NS345, we made a deletion mutant, pLZ3(50%C)45, which encodes a region starting from the C-terminal half of NS3 and ending with the entire NS5 sequence
(Fig. 1). Transient expression from this plasmid gave rise to
the unprocessed NS3(50% C terminal)45 precursor (Fig. 2C,
lane 2). Cotransfection of the plasmids encoding NS2B alone
or the NS3 protease domain alone [NS3(pro)] could not
mediate the processing of the NS3(50% C terminal)45 precursor (Fig. 2C, lanes 3 and 4, respectively). But when the
plasmids encoding NS2B and NS3(pro) were cotransfected
with the precursor plasmid pLZ-3(50%C)45, the NS4B-NS5
site of the precursor was cleaved, as shown by the release of
NS5 (Fig. 2C, lane 5). Cotransfection of the plasmid encoding the linked NS2B-NS3(pro) sequence also gave a similar
result (Fig. 2C, lane 6). However, cleavage of the NS3NS4A site was not detectable in these experiments (data not
shown). Two possible explanations could be invoked from
this result: the conformation assumed by precursor A having
a large deletion in the NS3 sequence might preclude cleavage
at the NS3-NS4A site, or the cis linkage of the NS3 protease
domain to NS4A is required for this cleavage, which is
abrogated in precursor A. To address this question, we made
a mutant plasmid, pLZ-3*45, in which the conserved protease triad residue His-51 was changed to Ala by site-directed
point mutagenesis by PCR (31). An additional mutation
(His-47- Asn), the origin of which was traced to the primer
oligonucleotide used for PCR, was also found to be present
in three independent clones by sequence analysis. Cotransfection of this plasmid with pLZ-2B showed that, unlike the
processing of the wild-type precursor (Fig. 2A and B, lanes
2), NS2B alone in trans was ineffective in the processing of
this mutant precursor NS3*45 and required coexpression of
wild-type NS3(pro) (Fig. 2A and B, lanes 3 and 4). These
experiments clearly indicated that the cis linkage of the
catalytically active protease domain of NS3 to the NS4A site
is not required for the cleavage at the NS3-NS4A site, as it
could be cleaved in trans by NS2B and NS3(pro).
The unprocessed precursors as well as the intermediates
formed in the processing of NS345 or NS3*45 are identifiable
by using anti-NS3 and anti-NS5 antibodies. For example, the
intermediate NS3-NS4A was detected by using anti-NS3
antibodies in the processing of the NS345 and NS3*45
precursors (Fig. 2A, lanes 2 and 4). The identity of this band
as to NS3-NS4A was confirmed by using additional expression constructs (29). Formation of an NS3-NS4A intermedi-

NOTES

VOL. 66, 1992

A~~~~~~~
A& ;~
--

^S
>N
_:

'9

.
I"

C
¢;-

;

-

NS

K

46 -

.-N;s

_

4

_

'

-' o

-\"b

,N'

r

v

.-;r

B

prtl

\

N>'
_
-li
--

}

- 1

Nie().
-Z -.
1-

or

69

46

A\

N: ''

..
._

a

4

1

2

3

4

5

6

7

FIG. 2. Processing of the NS345 precursor protein requires
NS2B and a catalytically active protease domain. Monolayers of
CV-1 cells in 25-cm2 flasks were infected with recombinant vaccinia
virus expressing T7 RNA polymerase (vTF7-3), except one indicated as DEN-2-infected, and then transfected with the expression
plasmid. Three hours posttransfection, the cells were metabolically
labeled with [35S]methionine for 4 to 5 h, and the cell lysates were
immunoprecipitated with the polyclonal antibodies raised against
the intact NS3 and NS5 proteins (29) and analyzed by sodium
dodecyl sulfate-polyacrylamide gel electrophoresis and autoradiography. (A) Rabbit polyclonal anti-NS3 antibody was used for
immunoprecipitations. The numbers on the left margin denote the
sizes of the protein standards in kilodaltons. Lanes: 1, negative
control (infection only; no DNA transfection); 2, plasmids pLZ-2B
and pLZ-345 were transfected; 3, plasmids pLZ-2B and pLZ-3*45
were transfected; 4, plasmids pLZ-2B, pLZ-3(pro), and pLZ-3*45
were transfected; 5, DEN-2 virus-infected CV-1 cell lysates. (B) The
samples were the same as in panel A except that the immunoprecipitates were derived from using rabbit polyclonal anti-NS5 antibody. (C) The immunoprecipitates were derived from using rabbit
polyclonal anti-NS5 antibody. Lanes: M, 14C-labeled protein molecular mass standards (kilodaltons); 1, negative control; 2, plasmid
pLZ-3(50%C)45 (referred to as A) was transfected; 3, plasmids A
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ate reactive with anti-NS3 antibodies is one evidence that
the cleavage of NS4A-NS4B had taken place in the processing of NS345. Since specific antibodies against these dengue
viral antigens, NS4A and NS4B, are not presently available,
we could not confirm independently the cleavage of the
NS4A-NS4B site by immunoprecipitation. However, the
efficiency of cleavage at the NS3-NS4A site of the precursor
NS345 or NS3*45 can be estimated from the ratio of the
mature NS3 (or the NS3*) to the unprocessed precursor
NS345 (or NS3*45) and the amount of the intermediate
NS3-NS4A formed (Fig. 2A, lanes 2 and 4); this efficiency
was better with the wild-type NS345 substrate, in which the
catalytically active NS3 protease domain was linked in cis to
NS4A and when only NS2B was supplied in trans (Fig. 2A,
lane 2), than with the processing of the mutant NS3*45
substrate, in which both the active NS3(pro) and NS2B were
supplied in trans. This observation may be explained by the
possibility that the NS3-NS4A site can be cleaved in both cis
and trans configurations during the processing of the wildtype substrate NS345; once a small fraction of the mature
NS3 is released by cis cleavage, the rest of NS3 can be
released from the precursor NS345 by both cis and trans
cleavages at the NS3-NS4A site. However, the cleavage of
the NS3-NS4A site in the NS3*45 precursor by NS2B and
NS3(pro) can occur only in the trans configuration. This
difference in the efficiency of cleavage at the NS3-NS4A site
was not observed for the cleavage at the NS4B-NS5 site of
the two substrates, as the intermediate NS4B-NS5 was not
formed at a level detectable with anti-NS5 antibodies (Fig.
2B, lanes 2 and 4). Although the NS4B-NS5 site can be
cleaved in trans mediated by NS2B and NS3(pro), we cannot
rule out the possibility that in the natural processing of the
DEN-2 polyprotein, a cis cleavage is involved if the catalytically active NS3(pro) domain in conjunction with NS2B is
brought in close proximity to the NS4B-NS5 site (see the
model in Fig. 4). Experiments are in progress to clarify this
aspect.
It is not yet understood what role NS2B plays in conjunction with NS3 in the processing of the precursor protein.
NS3 by itself may not have the right conformation for
protease activity, and it is possible that the interaction of
NS2B with NS3 confers protease activity for NS3. In this
regard, the proteolytic processing done by the NS2B and
NS3 proteins resembles the two-component protein requirement for the cleavage of amino-terminal targeting sequences
in the mitochondrial matrix of Neurospora crassa (13): the
57-kDa matrix processing peptidase having the catalytic site
and the 52-kDa processing enhancing protein. Matrix processing peptidase alone was shown to have a low processing
activity, whereas processing enhancing protein alone was
devoid of any activity, but it significantly enhanced the
processing activity of matrix processing peptide. It is unknown at present whether NS3 alone has any basal protease
activity in the absence of NS2B. It is possible that the
system used in this study may not be sensitive enough to
detect the low protease activity, if any, of NS3. Studies

using model substrates containing the dibasic cleavage sites
with sensitive detection methods may address this question.
We then examined the subcellular localization of the

and pLZ-2B were transfected; 4, plasmids A and pLZ-3(pro) were
transfected; 5, plasmids A, pLZ-2B, and the pLZ-3(pro) were
transfected; 6, plasmids A and pLZ-2B3(pro) were transfected; 7,
DEN-2-infected cell lysates.
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FIG. 3. Subcellular localization of the unprocessed precursor NS345. CV-1 cells were used for the infection-transfection protocol. The
cells were infected with the vTF7-3 virus (1 PFU per cell) at room temperature for 30 min. Subsequently, the vTF7-3-infected cells were
transfected with the indicated plasmid for 3 h. Cells were then incubated with Dulbecco modified Eagle medium containing 5% fetal bovine
serum for about 12 h. Cells were fixed for 30 min with paraformaldehyde (3.7%) in phosphate-buffered saline (PBS) (pH 7.4) and then treated
with Triton X-100 (0.1%) in PBS for 10 min. Cells were then washed with PBS for 30 min and prepared for indirect immunofluorescence with
anti-NS5 antibodies as previously described (30). (A) vTF7-3-infected cells as the negative control. (B) CV-1 cells were infected with DEN-2
virus at 1 PFU per cell for 1 h at room temperature. Then the cells were incubated with Dulbecco modified Eagle medium containing 10%
fetal bovine serum for 48 h before being fixed for immunofluorescence. (C) vTF7-3-infected cells were transfected with pLZ-345. (D)
Phase-contrast picture of cells in panel C. (E) Same as panel C, except transfected with pLZ-12345. (F) Phase-contrast picture of cells in panel
E.

polyprotein precursor NS345 by indirect immunofluorescence with rabbit polyclonal antibodies against purified NS3
and NS5. We found that the unprocessed precursor was
associated with some subcellular organelle in the cytoplasm
of the majority of cells transfected with the plasmid pLZ-345
(Fig. 3C), whereas the vTF7-3-infected cells alone were
negative in immunoreactivity with anti-NS5 antibodies (Fig.
3A). However, in the cells transfected with the plasmid
pLZ-12345 in which the precursor was processed efficiently

(29), the released NS5 was localized predominantly in the
perinuclear region, although some diffuse cytoplasmic distribution was also seen (Fig. 3E and F). It is interesting that
flavivirus replication sites were also localized in the perinuclear region by using antibodies to a double-stranded RNA
and autoradiographic and immunofluorescence techniques
(16, 20, 27). NS5 has been implicated in the replication of the
flavivirus genome (12). In the DEN-2-infected CV-1 cells
(Fig. 3B), NS5 was seen to be distributed in the perinuclear
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region, although some cytoplasmic and nuclear staining was
also seen (Fig. 3B). Thus, our results suggest that the
processing of the polyprotein precursor occurs at an intracellular site distinct from the site of localization of the
processed NS5. In fact, in Sindbis virus, a member of the
alphaviruses, it was shown that the precursor of the structural proteins and the cleavage products were destined to
different compartments (reviewed in reference 15). For
example, the mature capsid protein cleaved off from the
amino terminus of the precursor assembled in the cytoplasm,
whereas the C-terminal portion of this precursor is transported to the rough endoplasmic reticulum for further processing.
The precursor NS2B345 polyprotein could not be detected
in the YF-infected cells (5), probably due to a rapid cleavage
of the NS2B-NS3 site by the NS3 protease. This cleavage
event would give rise to the precursor NS345 as a transient
intermediate, the processing of which must await the trans
function of NS2B at the NS3-NS4A and NS4B-NS5 sites.
The transient existence of this precursor has been noted in
YF-infected cells by pulse-chase experiments (5) and in
DEN-2-infected cells (data not shown). Two points drawn
from the present experimental evidence suggest that the
precursor NS345 may assume a special conformation prior
to its processing into mature products. First, the NS4ANS4B site could not be cleaved in the DEN-2 precursor
NS345 (this study), in NS4A-NS4B (21), in the DEN-4
precursor NS345, or in the YF precursor NS345356 containing the truncated NS5 (2, 3); but this site could be cleaved in
NS34AI4B(84%) and NS4A4B5 (2, 8). Second, the NS345
precursor has several consensus cleavage sites, although
actual cleavage occurs only at the NS3-NS4A and NS4BNS5 sites.
The nonstructural proteins NS4A and NS4B consist of
hydrophobic membrane-spanning domains, and the N-terminal amino acid sequence data for Kunjin virus (KUN) and
YF suggest that the cleavage of the NS4A-NS4B site may
occur in the lumen of the rough endoplasmic reticulum.
NS4B has been identified in KUN- and YF-infected cells (5,
24), whereas NS4A has been identified only in KUN-infected cells (25). On the basis of our present knowledge
regarding DEN-2 polyprotein processing, we propose a
model for the conformation of the NS345 precursor (Fig. 4).
In this model, the NS4A-NS4B region subsequent to insertion into the endoplasmic reticulum membrane might confer
a cytoplasmic anchor for the precursor NS345 and thus
account for its localization seen in Fig. 3C. In the absence of
NS2B, the localization of NS345 may be confined to this
cytoplasmic organelle.
However, the polyprotein precursor NS12345 undergoes
processing mediated by NS2B linked in cis, and the released
NS5 was localized to the perinuclear region (Fig. 3B).
Assembly of the replication complexes at the perinuclear
region would require the localization of the genomic RNA at
this site to serve as a template for negative-strand synthesis
(for reviews, see references 1, 26, and 27). It is not clear how
the timing of the translation of the positive-strand RNA
genome into mature proteins and of its replication to progeny
RNA molecules is controlled. It is possible that the translation of the genomic RNA must precede its replication in
order to produce the nonstructural proteins required for
replication. NS3 has been implicated to play a dual role as
the protease as well the RNA helicase based on the presence
of conserved domains in the region C terminal to the
protease domain (11). NS5 protein has been implicated to
function as an RNA polymerase based on the presence of the

-
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* protease cleavage site

* putative signalase cleavage site
FIG. 4. Proposed model for the conformation of the unprocessed
NS345 precursor. The precursor is localized in the endoplasmic
reticulum (ER) membrane because of the hydrophobic sequences
present in NS4A and NS4B. The NS3 protease domain is indicated
by an arrow.

highly conserved G-D-D motif found in RNA-dependent
RNA polymerases of several positive-strand RNA viruses. It
is possible that the transient formation of the precursor
NS345 and subsequent processing to give rise to mature NS3
and NS5 might serve as a control point during the switch
from the translation mode of the viral RNA template into its
replication mode.
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critical reading of the manuscript.
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